+5 more ↓
69%
Finnrick rating
#7 of 40 Melanotan II vendors
8 of 11 classifiable tests passed
natural 73% · customers 4.6★ (5)
methodology · Purity focus
Finnrick analysis · Melanotan II

HK Peptides' Melanotan II rating is held back by recurring purity dips, not identity or fill failures. The 99.18–99.22% purity misses are the key pattern; batch IDs are often absent despite recent rebound tests.

methodology →
vendor intelligence report
Vendor Intelligence Report: HK Peptides

Corporate records and homepage evidence point past the Hong Kong branding to a mainland operating trail and a separate manufacturing-facing domain with verification friction. The report maps the HKMS PEP/HPT adjacency, copycat domains, crypto payment rails, and forum impersonation signals.

26 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.47
87%
125
2
Retatrutide
$1.09
86%
135
3
GHK-Cu
$0.07
85%
48
4
BPC-157
$1.36
78%
21
5
PT-141
-
74%
7
6
Melanotan IIselected
$0.41
69%
12
7
Cagrilintide
$2.30
64%
10
8
Semaglutide
$0.70
64%
10
9
Ipamorelin
$0.81
58%
13
10
Sermorelin
$1.57
49%
5
11
TB-500
$1.17
46%
9
12
Tesamorelin
$2.00
46%
33
13
CJC-1295
$1.90
29%
10
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%16 Jul 2025: 60%4 Aug 2025: 66%21 Oct 2025: 71%29 Oct 2025: 64%25 Nov 2025: 57%6 Dec 2025: 62%26 Jan 2026: 66%15 Feb 2026: 69%26 Feb 2026: 63%28 Apr 2026: 67%9 Jul 2026: 70%9 Aug 2026: current 69%60%57%69%Jul 25Aug 26
Showing Melanotan II tests only
HK Peptides Melanotan II test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
9 Jul 2026Pass
Tested
lab nameView COA
28 Apr 2026Pass
Tested
lab nameView COA
26 Feb 2026Fail
Tested
lab nameView COA
15 Feb 2026Pass
Tested
lab nameView COA
26 Jan 2026Pass
Tested
lab nameView COA
6 Dec 2025Pass
Tested
lab nameView COA
25 Nov 2025Fail
Tested
lab nameView COA
29 Oct 2025Fail
Tested
lab nameView COA
21 Oct 2025Pass
Tested
lab nameView COA
6 Aug 2025Incomplete
Tested
lab nameView COA
1-10 of 12

About HK Peptides test results from Finnrick

HK Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 13 peptides and 438 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HK Peptides peptides in this dataset are BPC-157 (21 tests) and Melanotan II (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.